424 related articles for article (PubMed ID: 28142119)
21. Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: Impact on non-alcoholic fatty liver disease.
Ganji SH; Kashyap ML; Kamanna VS
Metabolism; 2015 Sep; 64(9):982-90. PubMed ID: 26024755
[TBL] [Abstract][Full Text] [Related]
22. Phenylmethimazole abrogates diet-induced inflammation, glucose intolerance and NAFLD.
Patton A; Church T; Wilson C; Thuma J; Goetz DJ; Berryman DE; List EO; Schwartz F; McCall KD
J Endocrinol; 2018 Jun; 237(3):337-351. PubMed ID: 29666152
[TBL] [Abstract][Full Text] [Related]
23. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
24. Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice.
Yokohama K; Fukunishi S; Ii M; Nakamura K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K
Int J Mol Med; 2016 Nov; 38(5):1499-1506. PubMed ID: 28025996
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic Alteration of Hepatocytes in Non-Alcoholic Fatty Liver Disease.
Lakhani HV; Sharma D; Dodrill MW; Nawab A; Sharma N; Cottrill CL; Shapiro JI; Sodhi K
Int J Med Sci; 2018; 15(14):1591-1599. PubMed ID: 30588181
[TBL] [Abstract][Full Text] [Related]
26.
Wang JH; Hwang SJ; Lim DW; Son CG
Cells; 2021 Dec; 11(1):. PubMed ID: 35011585
[No Abstract] [Full Text] [Related]
27. Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease.
Carvajal S; Perramón M; Oró D; Casals E; Fernández-Varo G; Casals G; Parra M; González de la Presa B; Ribera J; Pastor Ó; Morales-Ruíz M; Puntes V; Jiménez W
Sci Rep; 2019 Sep; 9(1):12848. PubMed ID: 31492960
[TBL] [Abstract][Full Text] [Related]
28. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
Weiss TS; Lupke M; Ibrahim S; Buechler C; Lorenz J; Ruemmele P; Hofmann U; Melter M; Dayoub R
PLoS One; 2017; 12(9):e0184282. PubMed ID: 28877220
[TBL] [Abstract][Full Text] [Related]
29. Effects of Mogrosides on High-Fat-Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice.
Zhang X; Song Y; Ding Y; Wang W; Liao L; Zhong J; Sun P; Lei F; Zhang Y; Xie W
Molecules; 2018 Jul; 23(8):. PubMed ID: 30060618
[TBL] [Abstract][Full Text] [Related]
30. Molecular insights into the role of mitochondria in non-alcoholic fatty liver disease.
Lee J; Park JS; Roh YS
Arch Pharm Res; 2019 Nov; 42(11):935-946. PubMed ID: 31571145
[TBL] [Abstract][Full Text] [Related]
31. The PDE5 inhibitor udenafil ameliorates nonalcoholic fatty liver disease by improving mitochondrial function.
Yu HM; Chung HK; Park KS
Biochem Biophys Res Commun; 2021 Jun; 558():57-63. PubMed ID: 33895552
[TBL] [Abstract][Full Text] [Related]
32. Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation.
Barbier-Torres L; Fortner KA; Iruzubieta P; Delgado TC; Giddings E; Chen Y; Champagne D; Fernández-Ramos D; Mestre D; Gomez-Santos B; Varela-Rey M; de Juan VG; Fernández-Tussy P; Zubiete-Franco I; García-Monzón C; González-Rodríguez Á; Oza D; Valença-Pereira F; Fang Q; Crespo J; Aspichueta P; Tremblay F; Christensen BC; Anguita J; Martínez-Chantar ML; Rincón M
Nat Commun; 2020 Jul; 11(1):3360. PubMed ID: 32620763
[TBL] [Abstract][Full Text] [Related]
33. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
[TBL] [Abstract][Full Text] [Related]
34. Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease.
Gaemers IC; Stallen JM; Kunne C; Wallner C; van Werven J; Nederveen A; Lamers WH
Biochim Biophys Acta; 2011 Apr; 1812(4):447-58. PubMed ID: 21216282
[TBL] [Abstract][Full Text] [Related]
35. Glycyrrhetinic acid attenuates disturbed vitamin a metabolism in non-alcoholic fatty liver disease through AKR1B10.
Shi L; Guo S; Zhang S; Gao X; Liu A; Wang Q; Zhang T; Zhang Y; Wen A
Eur J Pharmacol; 2020 Sep; 883():173167. PubMed ID: 32485245
[TBL] [Abstract][Full Text] [Related]
36. Effects of açai on oxidative stress, ER stress, and inflammation-related parameters in mice with high fat diet-fed induced NAFLD.
de Freitas Carvalho MM; Lage NN; de Souza Paulino AH; Pereira RR; de Almeida LT; da Silva TF; de Brito Magalhães CL; de Lima WG; Silva ME; Pedrosa ML; da Costa Guerra JF
Sci Rep; 2019 May; 9(1):8107. PubMed ID: 31147590
[TBL] [Abstract][Full Text] [Related]
37. Cholesterol Induces Nrf-2- and HIF-1
Kaminsky-Kolesnikov Y; Rauchbach E; Abu-Halaka D; Hahn M; García-Ruiz C; Fernandez-Checa JC; Madar Z; Tirosh O
Oxid Med Cell Longev; 2020; 2020():5393761. PubMed ID: 32566088
[TBL] [Abstract][Full Text] [Related]
38. Adrenic acid as an inflammation enhancer in non-alcoholic fatty liver disease.
Horas H Nababan S; Nishiumi S; Kawano Y; Kobayashi T; Yoshida M; Azuma T
Arch Biochem Biophys; 2017 Jun; 623-624():64-75. PubMed ID: 28456640
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of MD2-dependent inflammation attenuates the progression of non-alcoholic fatty liver disease.
Zhang Y; Wu B; Zhang H; Ge X; Ying S; Hu M; Li W; Huang Y; Wang L; Chen C; Shan X; Liang G
J Cell Mol Med; 2018 Feb; 22(2):936-947. PubMed ID: 29077272
[TBL] [Abstract][Full Text] [Related]
40. miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21.
Xiao J; Bei Y; Liu J; Dimitrova-Shumkovska J; Kuang D; Zhou Q; Li J; Yang Y; Xiang Y; Wang F; Yang C; Yang W
J Cell Mol Med; 2016 Feb; 20(2):204-16. PubMed ID: 26648452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]